Penn Medicine Provider
Breast Surgery
Julia C. Tchou, MD, PhD, FACS
she/her
4.9
(669)
Accepting new patients
Sees patients age 18 and up
Penn Breast Surgery Valley Forge
View 2 additional locations

About me

  • Director of Breast Surgery Research
  • Program Director, Breast Surgical Oncology Fellowship
  • Professor of Clinical Surgery

Education and training

  • Medical School: State University of New York at Stony Brook
  • Residency: Johns Hopkins Hospital
  • Fellowship: Johns Hopkins Hospital
  • Fellowship: Northwestern Memorial Hospital

What my patients think about me

Average Rating
4.9

671 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
she is good.
May 2025
5.0
5.0
she's the best!
May 2025
5.0
5.0
i feel confident with dr. tchou's knowledge and expertise.
May 2025
5.0
5.0
Dr. Tchou is very skilled and personable who always provided me with a peace of mind

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital: Has privileges to treat patients in the hospital.
Dr. Tchou is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Manik R, Grady CB, Elmore LC, Fieber JH, Freedman GM, Jankowitz RC, Tchou JC, Zhang JQ, Hubbard RA, Fayanju OM Temporal trends and factors associated with receipt of post-mastectomy radiation after neoadjuvant chemotherapy in women with cT3 breast cancer , Annals of Surgical Oncology, 30(11): 2023,6506-6515


Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas CV, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, Alvarado MD, Yang RL, Chan TW, Sheade JB, Ahrendt GM, Larson KE, Switalla K, Tuttle TM, Tchou JC, Rao R, Tamirisa N, Singh P, Gould RE, Terando A, Sauder C, Hewitt K, Chiba A, Esserman LJ, Mukhtar RA Changes in surgical management of the axilla over 11 years - Report on more than 1500 breast cancer patients treated with neoadjuvant chemotherapy on the prospective I-SPY2 trial , Annals of Surgical Oncology, 30(11): 2023,6401-6410


Perry NJ, Sharon CE, Tortorello GN, Ma KL, Straker RJ 3rd, Fayanju OM, Tchou JC, Miura JT, Karakousis GC Impact of travel burden on the treatment of stage I and II breast cancer: A National Cancer Database analysis , Surgery, 74(4): 2023,794-800


Mukhtar RA, Chau H, Woriax H, Piltin M, Ahrendt G, Tchou J, Yu H, Ding Q, Dugan CL, Sheade J, Crown A, Carr M, Wong J, Son J, Yang R, Chan T, Terando A, Alvarado M, Ewing C, Tonneson J, Tamirisa N, Gould R, Singh P, Godellas C, Larson K, Chiba A, Rao R, Sauder C, Postlewait L, Lee MC, Symmans WF, Esserman LJ, Boughey JC; ISPY-2 Locoregional Working Group Breast conservation surgery and mastectomy have similar locoregional recurrence following neoadjuvant chemotherapy: Results from 1,462 patients on the prospective, randomized I-SPY2 trial , Annals of Surgery, 278(3): 2023,320-327


Freedman GM, Li T, Garver E, Shillington K, Shinkle B, Tchou JC, Fayanju OM, Lin L, Taunk NK Five-year outcomes of a phase 1/2 trial of accelerated partial breast irradiation using proton therapy for women with stage 0-IIA breast cancer , Advances in Radiation Oncology, 9(2): 2023,101334


Sharon CE, Wang M, Tortorello GN, Perry NJ, Ma KL, Tchou JC, Fayanju OM, Mahmoud NN, Miura JT, Karakousis GC Impact of patient comorbidities on presentation stage of breast and colon cancers , Annals of Surgical Oncology, 30(8): 2023,4617-4626


Shah PD, Huang AC, Xu X, Orlowski R, Amaravadi RK, Schuchter LM, Zhang P, Tchou J, Matlawski T, Cervini A, Shea J, Gilmore J, Lledo L, Dengel K, Marshall A, Wherry EJ, Linette GP, Brennan A, Gonzalez V, Kulikovskaya I, Lacey SF, Plesa G, June CH, Vonderheide RH, Mitchell TC Phase I trial of autologous RNA-electroporated cMET-directed CAR T cells administered intravenously in patients with melanoma and breast carcinoma , Cancer Research Communications, 3(5): 2023,821-829


Uslu U, Da T, Assenmacher CA, Scholler J, Young RM, Tchou J, June CH Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma , Science Advances, 9(2): 2023,eade2526


Burkbauer L, Goldbach M, Hoffman DI, Giannakou A, Dultz R, Brooks AD, Sataloff DM, Keele L, Tchou J Preoperative MRI and its impact on surgical outcomes in patients with triple negative breast cancer treated with primary surgery: Did new margin guidelines or cavity shave margins practice diminish the role of preoperative MRI? , Annals of Surgical Oncology: 2022 (Epub)


Osdoit M, Yau C, Symmans WF, Boughey JC, Ewing CA, Balassanian R, Chen YY, Krings G, Wallace AM, Zare S, Fadare O, Lancaster R, Wei S, Godellas CV, Tang P, Tuttle TM, Klein M, Sahoo S, Hieken TJ, Carter JM, Chen B, Ahrendt G, Tchou J, Feldman M, Tousimis E, Zeck J, Jaskowiak N, Sattar H, Naik AM, Lee MC, Rosa M, Khazai L, Rendi MH, Lang JE, Lu J, Tawfik O, Asare SM, Esserman LJ, Mukhtar RA Association of residual ductal carcinoma in situ with breast cancer recurrence in the neoadjuvant I-SPY2 trial , JAMA Surgery, 157(11): 2022,1034-1041